ConductScience.org, home

Paper31311005

How and when to use temozolomide to treat aggressive pituitary tumours.

Whitelaw BC. Endocr Relat Cancer, 2019. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. How and when to use temozolomide to treat aggressive pituitary tumours. Papers, record 31311005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31311005

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
How and when to use temozolomide to treat aggressive pituitary tumours.
PubMed
Journal
Endocr Relat Cancer
PubMed
Year
2019
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
1.41
iCite
Revised in PubMed
2020-07-20
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Whitelaw BCBen C

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Agents, AlkylatingMajor topic
Neoplasm Recurrence, LocalMajor topic
Pituitary NeoplasmsMajor topic
TemozolomideMajor topic
Humans
Prognosis
Time-to-Treatment

Source PubMed

Download CSV of topics

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
42150200Cervical vertebral body metastasis from a gonadotroph pituitary neuroendocrine tumor: illustrative case.J Neurosurg Case Lessons2026https://conductscience.org/library/papers/42150200PubMed
41894067Temozolomide in aggressive and metastatic pituitary tumors: a Brazilian multicenter real-world cohort study.Pituitary2026https://conductscience.org/library/papers/41894067PubMed
40806825Management of Recurrent and Aggressive Non-Functioning Pituitary Adenomas.J Clin Med2025https://conductscience.org/library/papers/40806825PubMed
40804505Consensus on acromegaly therapeutic outcomes: an update.Nat Rev Endocrinol2025https://conductscience.org/library/papers/40804505PubMed
40362297Liquid Biopsy in Pituitary Neuroendocrine Tumors-Potential Biomarkers for Diagnosis, Prognosis, and Therapy.Int J Mol Sci2025https://conductscience.org/library/papers/40362297PubMed
40236482Exploring the gut microbiome and serum metabolome interplay in non-functioning pituitary neuroendocrine tumors.Front Microbiol2025https://conductscience.org/library/papers/40236482PubMed
38706730Enhancing glioma-specific drug delivery through self-assembly of macrophage membrane and targeted polymer assisted by low-frequency ultrasound irradiation.Mater Today Bio2024https://conductscience.org/library/papers/38706730PubMed
36856733Aggressive Pituitary Tumors and Pituitary Carcinomas: From Pathology to Treatment.J Clin Endocrinol Metab2023https://conductscience.org/library/papers/36856733PubMed
35865778Aggressive prolactinomas responsive to temozolomide treatment: Report of two cases.Clin Case Rep2022https://conductscience.org/library/papers/35865778PubMed
35368902A Retrospective Trail Investigating Temozolomide Neoadjuvant Chemotherapy Combined with Radiotherapy in Low-Grade Pituitary Tumors.J Oncol2022https://conductscience.org/library/papers/35368902PubMed
34975752Early Initiation of Temozolomide Therapy May Improve Response in Aggressive Pituitary Adenomas.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/34975752PubMed
34934445Aggressive prolactinoma (Review).Exp Ther Med2022https://conductscience.org/library/papers/34934445PubMed
34900530Sinomenine ester derivative inhibits glioblastoma by inducing mitochondria-dependent apoptosis and autophagy by PI3K/AKT/mTOR and AMPK/mTOR pathway.Acta Pharm Sin B2021https://conductscience.org/library/papers/34900530PubMed
34867776Treatment of Aggressive Pituitary Adenomas: A Case-Based Narrative Review.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/34867776PubMed
34840971Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis.Biomed Res Int2021https://conductscience.org/library/papers/34840971PubMed
34493834Aggressive pituitary tumours and pituitary carcinomas.Nat Rev Endocrinol2021https://conductscience.org/library/papers/34493834PubMed
34220707Aggressive Cushing's Disease: Molecular Pathology and Its Therapeutic Approach.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/34220707PubMed
33776913Case Report: Temozolomide Treatment of Refractory Prolactinoma Resistant to Dopamine Agonists.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/33776913PubMed
33763363Characteristic of Tumor Regrowth After Gamma Knife Radiosurgery and Outcomes of Repeat Gamma Knife Radiosurgery in Nonfunctioning Pituitary Adenomas.Front Oncol2021https://conductscience.org/library/papers/33763363PubMed
32914330Multidisciplinary management of acromegaly: A consensus.Rev Endocr Metab Disord2020https://conductscience.org/library/papers/32914330PubMed

See all 21 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MGMT4255PubTator's text mininghttps://conductscience.org/library/genes/4255

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31311005

GET https://conductscience.org/api/papers/v1/31311005/cited_by?page=2